All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

BMED ETF · iShares Health Innovation Active ETF

The BMED Exchange Traded Fund (ETF) is provided by iShares. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofHealthcare Technology1M perf.-3.24%
Last price
$28.73
1M perf.
-2.31%
1M flows
N/A
AuM
€9M
E/R
0.77%
Rating
Not rated
ESG Consensus®
esg grade icon
BMED
$28.73

Performance & flows

Segment for quartile rank
January 6, 2026 → April 6, 2026
0-15-10-50%FEBMARAPRFEBMARAPR
Create a free account to view the flows graph
BMED
$28.73
-7.61%
Healthcare Technology
-10.41%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-2.31%
icon
-7.61%
icon
+29.20%
icon
+21.50%
icon
+0.74%
-0.54%
-0.54%
-5.16%
icon
Flows

Key fund info

Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) · 
Main characteristics
Issuer
CUSIP
09290C400
ISIN
US09290C4006
AuM
€9M
icon
E/R
0.77%
icon
ESG Consensus®
esg grade icon
More details
NAV
4/6/2026
$28.73
1D NAV change
-0.65%
Dividend policy
No. of holdings
50
Inception date
9/29/2020
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Fund
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The iShares Health Innovation Active ETF (the “Fund”) seeks to maximize total return by investing in innovative and emerging companies in the healthcare sector.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
See all Trackinsight Enterprise features

Trackinsight
Enterprise

Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight Enterprise

Similar ETFs in your region

IXJ
1M perf.
-4.17%
E/R
0.47%
XHC
1M perf.
-5.92%
E/R
0.66%
LMAX
1M perf.
-1.14%
E/R
0.8%
ZWHC
1M perf.
-0.43%
E/R
0.73%
PJP
1M perf.
-1.60%
E/R
0.57%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
-7.61%
icon
+29.21%
icon
+21.50%
icon
+0.74%
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
88.81%
Switzerland
6.47%
Cayman Islands
3.43%
United Kingdom
2.21%
Belgium
1.53%
Sectors
Health Care
91.63%
Unavailable
8.37%
Diversification
Total weight of top 15 holdings out of 50
Top 15 holdings
Data as of February 28, 2026
JOHNSON&JOHNSON
AMGEN-T
MERCK & CO INC
INTUITIVE SURGICAL
MCKESSON
AMERISOURCEBERGEN
EDWARDS LIFESCIENCES
IDEXX LABORATORIES
Create a free account to view top holdings
DANAHER
WUXI BIOLOGICS (CAYMAN)
GILEAD SCIENCES
US8816242098
METTLER TOLEDO
WATERS
CHRLS RIVER LABS
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
No
SDG
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Issuer

iShares
iShares ID Card
Number of funds
1733
Total AuM
€4.92T
Expense ratio range
0.03% - 1.51%
Average expense ratio
0.2839%

Frequently asked questions about BMED

What does iShares Health Innovation Active ETF, BMED, invest in?

BMED is a Active ETF. This ETF provides exposure to Other Equities.

What is the Total Expense ratio (TER) of BMED?

BMED carries a total expense ratio (TER) of 0.77%, indicating the annual cost for holding the fund.

When was BMED launched?

BMED was introduced to the market on September 29, 2020. It trades on United States

Who is the ETF issuer of BMED?

iShares Health Innovation Active ETF, BMED, is provided by iShares. Learn more about iShares here.

What is the current assets under management (AUM) of BMED?

BMED oversees €9M in assets as of April 6, 2026.

How has BMED performed lately?

Based on data from April 6, 2026, BMED returned -2.31% over the past month, -7.61% over the last three months and -5.16% year-to-date.

What are the latest inflows or outflows for BMED?

As of April 6, 2026, BMED recorded net flows of +€3.1M year-to-date.

Does BMED distribute dividends?

BMED follows a distributing dividend policy, meaning it pays out income to investors.

What are the main country or region exposures of BMED?

As of February 28, 2026, BMED has significant geographic allocations in USA, Switzerland and Cayman Islands.

In which sector or theme does BMED invest in?

As of February 28, 2026, BMED focuses largely on Health Care.

How many securities does BMED hold and how diversified is it?

As of February 28, 2026, BMED holds 50 positions in its portfolio, with 59.71% of assets concentrated in its top 15 holdings.

What are the main positions in BMED?

As of February 28, 2026, BMED top three holdings include JOHNSON&JOHNSON, AMGEN-T and MERCK & CO INC.

What is the base currency of BMED?

The base currency of BMED is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight